Cryomass Technologies (Cryomass Technologies) FCF Margin % : 0.00% (As of Sep. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Cryomass Technologies FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Cryomass Technologies's Free Cash Flow for the three months ended in Sep. 2023 was $-0.90 Mil. Cryomass Technologies's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Cryomass Technologies's FCF Margin % for the quarter that ended in Sep. 2023 was 0.00%.

As of today, Cryomass Technologies's current FCF Yield % is -36.68%.

The historical rank and industry rank for Cryomass Technologies's FCF Margin % or its related term are showing as below:

During the past 12 years, the highest FCF Margin % of Cryomass Technologies was -0.11%. The lowest was -10183.33%. And the median was -480.15%.

CRYM's FCF Margin % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.08
* Ranked among companies with meaningful FCF Margin % only.

Cryomass Technologies FCF Margin % Historical Data

The historical data trend for Cryomass Technologies's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryomass Technologies FCF Margin % Chart

Cryomass Technologies Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

FCF Margin %

Get a 7-Day Free Trial

-10,183.33

-480.15

Cryomass Technologies Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Cryomass Technologies's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Cryomass Technologies's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryomass Technologies's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cryomass Technologies's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Cryomass Technologies's FCF Margin % falls into.

Cryomass Technologies FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Cryomass Technologies's FCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2022 )	/	Revenue (A: Dec. 2022 )
	=	-5.167	/	0
	=	%

Cryomass Technologies's FCF Margin for the quarter that ended in Sep. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-0.9	/	0
	=	%

Cryomass Technologies FCF Margin % Related Terms

Thank you for viewing the detailed overview of Cryomass Technologies's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryomass Technologies (Cryomass Technologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cryomass Technologies Inc (OTCPK:CRYM) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

1001 Bannock Street, Suite 612, Denver, CO, USA, 80204

Website

https://www.cryomass.com

Cryomass Technologies Inc designs, manufactures, and licenses field-mobile equipment for the handling of harvested cannabis, hemp, and other high-value plant material. The company owns patented technology that utilizes liquid nitrogen to fully separate, collect and protect the high-value compounds from the harvested plant. The company's offerings include refinement systems and monitoring and control systems.

Executives

Philip Blair Mullin	officer: Chief Financial Officer	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Christian Noel	director, officer: Chief Executive Officer	3531 SOUTH LOGAN ST. SUITE D-357, ENGLEWOOD CO 80113
Patricia Izabel Kovacevic	officer: GC, Corp Secy, and Head of EA	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Delon Hannes Human	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mark Radke	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113
Mario Gobbo	director	3531 SOUTH LOGAN STREET, SUITE D-357, ENGLEWOOD CO 80113